JAHB(SH:603822)2022-04-22 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥516,622,293.80, representing a year-on-year increase of 62.09%[5] - The net profit attributable to shareholders for Q1 2022 was ¥28,097,973.53, an increase of 33.82% compared to the same period last year[5] - The basic earnings per share for Q1 2022 was ¥0.3830, reflecting a growth of 33.82% year-on-year[6] - The diluted earnings per share for Q1 2022 was ¥0.3693, which is a 30.60% increase from the previous year[6] - The weighted average return on equity for Q1 2022 was 3.06%, an increase of 0.54 percentage points compared to the previous year[6] - The total operating revenue for Q1 2022 reached RMB 516,622,293.80, an increase of 62.0% compared to RMB 318,726,377.14 in Q1 2021[21] - In Q1 2022, the company reported a net profit of CNY 28,586,410.35, an increase of 35% compared to CNY 21,133,561.35 in Q1 2021[22] - The operating profit for Q1 2022 was CNY 28,363,199.24, up from CNY 23,331,437.17 in the same period last year, reflecting a growth of approximately 21%[22] - The total revenue from sales of goods and services reached CNY 520,562,698.73, a significant increase of 78.5% compared to CNY 291,933,049.50 in Q1 2021[25] - The total comprehensive income for Q1 2022 was CNY 28,586,410.35, compared to CNY 21,133,561.35 in Q1 2021, reflecting an increase of approximately 35%[23] Assets and Liabilities - The total assets at the end of Q1 2022 were ¥2,569,447,969.29, up 4.36% from the end of the previous year[6] - The company's total assets as of March 31, 2022, amounted to RMB 2,569,447,969.29, compared to RMB 2,462,166,561.49 at the end of Q1 2021, reflecting a growth of 4.4%[18] - Current assets totaled RMB 1,140,634,271.35, slightly up from RMB 1,100,608,288.56 in the previous year, indicating a growth of 3.6%[16] - Current liabilities increased to RMB 1,077,526,552.02 from RMB 958,664,930.02, representing a rise of 12.4%[17] - Non-current assets reached RMB 1,428,813,697.94, an increase of 4.9% from RMB 1,361,558,272.93 in the previous year[17] - The company's total liabilities were RMB 1,600,187,284.00, compared to RMB 1,525,395,623.94 in the previous year, marking an increase of 4.9%[18] - Shareholders' equity totaled RMB 969,260,685.29, up from RMB 936,770,937.55, reflecting a growth of 3.5%[18] Cash Flow - The net cash flow from operating activities for Q1 2022 was -¥21,699,621.44, which is not applicable for year-on-year comparison[5] - The company experienced a net cash outflow from operating activities of CNY -21,699,621.44, worsening from CNY -10,442,399.71 in Q1 2021[26] - Cash and cash equivalents at the end of Q1 2022 stood at CNY 258,716,978.00, compared to CNY 237,656,285.51 at the end of Q1 2021[27] - The company reported cash and cash equivalents of approximately 336.70 million, consistent with the previous period[30] - The company reported a cash inflow from financing activities of CNY 20,429,235.53 in Q1 2022, a turnaround from a cash outflow of CNY -21,661,430.51 in Q1 2021[27] Inventory and Costs - The increase in operating revenue was primarily driven by the rise in sales volume and price of the biomass energy segment[9] - The company reported an increase in inventory of 6,039.166 tons of biodiesel, which is expected to be sold after the quarterly report[9] - Total operating costs for Q1 2022 were RMB 501,829,088.22, up 70.3% from RMB 294,851,669.50 in Q1 2021[21] - The company incurred R&D expenses of CNY 11,774,701.46 in Q1 2022, slightly down from CNY 12,574,817.18 in Q1 2021[22] - Financial expenses increased to CNY 10,350,710.13 in Q1 2022, compared to CNY 7,978,584.58 in the same quarter last year, marking a rise of approximately 30%[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,023[11] Future Outlook - The company reported a net profit margin improvement, with net profit figures to be detailed in future reports[21] - The company is focusing on expanding its market presence and enhancing product development strategies in the upcoming quarters[21] Accounting Changes - The company implemented new accounting standards affecting revenue recognition from trial production sales starting January 1, 2022[32]